The book is divided into thirteen chapters, focusing on cardiovascular comorbid conditions, with extensive coverage of cardiovascular disease management in patients with co-existing diabetes, dysmetabolic syndrome and pregnancy. The first two chapters cover vasodilators and neurohormone modulators, and positive inotropic drugs, and subsequent chapters cover drugs for specific conditions including dyslipidemia, dysrhythmia, stable angina, and pulmonary hypertension.
The final chapter 'Future Direction - Pharmacogenomics' provides insight into the exploration of the human genome for opportunities to improve therapeutic precision in cardiovascular medicine. This new edition ofCardiac Drugsalso incorporates the latest JNC 8 (Joint National Committee) guidelines on hypertension, highlighting their key differences to previous guidelines.